Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One-year Double-blind Placebo-controlled Phase 2-3 Study to Evaluate the Effect of Oral Folinic Acid Treatment (1mg/kg/d) on the Psychomotor Development of Young Down Syndrome Patients

NCT00294593 is registered in ClinicalTrials.gov with Institut Jerome Lejeune as lead sponsor.

NCT NCT00294593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00294593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One-year Double-blind Placebo-controlled Phase 2-3 Study to Evaluate the Effect of Oral Folinic Acid Treatment (1mg/kg/d) on the Psychomotor Development of Young Down Syndrome Patients
Lead sponsor
Institut Jerome Lejeune
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2000
Completion date
December 31, 2003
Enrollment
120
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome